The most significant recent advance in tinnitus treatment is bimodal neuromodulation, a technique that pairs sounds with mild electrical stimulation of the tongue to retrain the brain’s response to phantom noise. The first device using this approach, called Lenire, received FDA approval and is now available in the United States. But it’s far from the only option gaining traction. Several new therapies, from app-based psychological programs to experimental drugs, are expanding what’s possible for the roughly 15% of adults who live with persistent ringing, buzzing, or hissing in their ears.
Bimodal Neuromodulation: The First FDA-Cleared Device
Lenire, manufactured by Neuromod Devices, is the first device of its kind to receive FDA De Novo approval for treating tinnitus. It works by delivering sounds through headphones while simultaneously sending gentle electrical pulses to the tongue through a small mouthpiece. The idea is that combining two types of sensory input pushes the brain to reorganize its neural activity, essentially turning down the volume on tinnitus signals. You use the device for up to 60 minutes a day at home.
Clinical trial results across more than 600 patients have been consistent. Among patients with moderate or worse tinnitus, 81.8% achieved a clinically significant improvement after just 12 weeks, with an average reduction of nearly 24 points on the Tinnitus Handicap Inventory (a standard questionnaire where lower scores mean less disruption to daily life). That’s a meaningful shift, often enough to move someone from “moderate” to “mild” tinnitus. The device doesn’t eliminate tinnitus for most people, but it can substantially reduce how much it bothers you.
Digital Cognitive Behavioral Therapy
Cognitive behavioral therapy has long been the psychological treatment with the strongest evidence for tinnitus distress. What’s new is that effective versions now exist online and through smartphone apps, making it far more accessible than weekly in-person sessions with a specialist.
Internet-based CBT programs guided by a therapist have shown large effect sizes in multiple trials. In one study, 65% of participants achieved a successful outcome, defined as a 13-point or greater drop on the Tinnitus Functional Index. Another found that 42% of participants met the threshold for clinically significant change, with benefits maintained at follow-up. These programs typically involve structured modules on attention redirection, relaxation techniques, and changing thought patterns around tinnitus over several weeks.
Smartphone apps are also showing promise. Across several trials, between 38% and 50% of users experienced meaningful improvement. One app-based program produced a large effect size of 1.71 on the Tinnitus Handicap Inventory, comparable to what you’d expect from face-to-face therapy. The key distinction is that CBT doesn’t try to eliminate the sound itself. It changes your brain’s emotional and attentional response to it, which for many people is what actually determines whether tinnitus ruins their day or fades into the background.
Sound Therapy: What Works Best
Sound therapy remains a practical, everyday tool for tinnitus management. The goal isn’t necessarily to drown out the sound completely. Most clinicians now recommend setting the volume at or just below the “mixing point,” where external sound partially blends with the tinnitus rather than fully covering it. This partial masking appears to promote habituation over time, training the brain to deprioritize the tinnitus signal.
Clinical guidelines suggest that masking treatment works best for people whose tinnitus can be masked by sounds within about 10 decibels of their tinnitus loudness. For best results, it’s recommended to use sound therapy in a quiet environment for at least 45 minutes a day through headphones or earphones. If your tinnitus is in one ear, using sound in that ear alone tends to be more effective. White noise, nature sounds, and notched audio (where frequencies matching your tinnitus are filtered out) are all common choices, and many are available through free or low-cost apps.
Cochlear Implants for Severe Hearing Loss
For people with severe-to-profound hearing loss who also have tinnitus, cochlear implants offer a notable secondary benefit. In a study of 38 implant recipients, 92% experienced a reduction in tinnitus intensity. The implant restores sound input to the auditory nerve, which appears to quiet the overactive neural signals that produce tinnitus in a damaged ear. This isn’t a standalone tinnitus treatment since you need to meet the criteria for cochlear implantation based on hearing loss. But if you’re already a candidate, tinnitus relief is a well-documented bonus.
Experimental Drug Treatments
No drug is currently approved specifically for tinnitus, but the pipeline is more active than it’s been in years. One of the most promising directions involves a class of compounds that activate specific potassium channels in auditory brain cells. Researchers at UPMC developed a compound called RL-81 that targets these channels. In mice with noise-induced tinnitus, the compound significantly reduced signs of tinnitus without affecting hearing loss. The underlying theory is straightforward: after noise damage, certain brain cells become hyperactive because their potassium channels stop working properly. RL-81 reactivates those channels, calming the overexcited neurons. It’s still in preclinical development, but it represents the most targeted drug approach to date.
Other compounds targeting inner ear protection are also in testing. SENS-401, which blocks serotonin receptors and inhibits a cellular stress pathway called calcineurin, has been studied in Phase 2 trials for sudden hearing loss. While its direct effect on tinnitus hasn’t been reported in detail yet, the rationale is that protecting inner ear cells from damage could prevent tinnitus from developing in the first place.
Deep Brain Stimulation: Early but Striking
For the most severe, treatment-resistant cases, deep brain stimulation is being explored. In a published case report, a patient with refractory tinnitus received electrodes implanted in the medial geniculate body, a relay station in the thalamus where auditory signals pass on their way to the cortex. The results were striking: the patient experienced major improvement in tinnitus burden, along with reduced depression and anxiety. This is still a single case, and brain surgery carries inherent risks, so it’s far from a standard option. But it demonstrates that directly modulating the brain’s auditory processing centers can work when nothing else has.
Choosing the Right Approach
Tinnitus treatment in 2025 is not one-size-fits-all, and most specialists recommend combining approaches. Someone with mild tinnitus might do well with a sound therapy app and a digital CBT program. Someone with moderate-to-severe symptoms might benefit from Lenire alongside structured therapy. And someone with profound hearing loss might find that a cochlear implant addresses both their hearing and their tinnitus simultaneously.
The shift in recent years has been away from telling patients there’s nothing to be done. Between the first FDA-cleared neuromodulation device, validated digital therapy programs, and a genuine drug development pipeline, the range of evidence-backed options is broader than at any point in the past. The most effective strategy typically addresses both the neural signal and your brain’s reaction to it, rather than targeting one or the other alone.